and Respiratory Syncytial Virus Stimulation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |
Abstract |
|---|
|
|
|---|
High levels of neutrophils and the neutrophil-attracting chemokine interleukin (IL)-8 have been observed
in the airways of patients with cystic fibrosis (CF). We hypothesized that CF respiratory epithelium produces excessive amounts of IL-8 either at baseline or after stimulation. To test this hypothesis we compared immunoreactive IL-8 release by primary nasal epithelial cell (NEC) cultures established from young
children with or without CF, at several time points after stimulation of cultures with tumor necrosis factor-
(TNF-
) or infection with respiratory syncytial virus (RSV). Both stimuli induced significantly increased IL-8 release by both CF and control cultures. However, there was no difference between CF and
control cells in either the magnitude or duration of the IL-8 response. The effect of transduction of CF cells
with Ad5-CBCFTR, an adenovirus vector mediating expression of cystic fibrosis transmembrane regulator (CFTR), on IL-8 production was also determined. TNF-
stimulated IL-8 production was not different in
Ad5-CBCFTR-transduced, -untransduced, or Ad5-CMVLacZ-transduced control cells. Lastly, immortalized CF tracheal epithelial cell lines, both uncorrected and retrovirally corrected with CFTR, were compared. Again, TNF-
-stimulated IL-8 production did not differ significantly between cell lines with and
without functioning CFTR. Our data suggest that isolated CF NECs cultured under these conditions do not
produce more IL-8 than do non-CF control cultures, either at baseline or after incubation with the nonspecific stimuli TNF-
and RSV. We conclude that the absence of functioning CFTR alone is not sufficient to
cause excessive production of IL-8.
| |
Introduction |
|---|
|
|
|---|
Progressive lung disease in cystic fibrosis (CF) is largely due to persistent inflammation characterized by an abundance of activated neutrophils (1). The influx of neutrophils into CF airways has been traditionally thought to be a response to chronic infection with bacteria (2). However, recent bronchoalveolar lavage (BAL) studies have documented elevated levels of neutrophils in the lower airways of some infants with CF even in the absence of detectable infection (3, 4). These observations are consistent with the hypothesis that inflammation is abnormally regulated in CF airways. Attention has been focused on interleukin (IL)-8, a chemokine that accounts for most of the neutrophil chemoattractant activity of CF sputum (5) and is repeatedly found in elevated concentrations in the airways of patients with CF.
A potentially major source of IL-8 in the airways is the
respiratory epithelium (6, 7). Since the respiratory epithelium also manifests the most important phenotypic abnormality of CF, we hypothesized that CF airway epithelial
cells overproduce IL-8, and that this is linked to abnormal
function of the cystic fibrosis transmembrane regulator
(CFTR). To test this hypothesis, we compared IL-8 production in CF and non-CF primary nasal epithelial cell (NEC) cultures at baseline and after stimulation with tumor necrosis factor-
(TNF-
) or infection by respiratory
syncytial virus (RSV). Nasal epithelium was used because
it has the same ion transport abnormalities as lower airway
epithelium in CF (8), is relatively free of inflammation
early in life (4), and can be obtained from young children
in a relatively noninvasive fashion. We additionally tested
the effect of "correction" by transduction with adenoviral vectors carrying the wild-type CFTR complementary
DNA (cDNA) of CF nasal epithelial IL-8 production. We
also compared IL-8 production by an immortalized CF epithelial cell line and the same cell line permanently corrected with retroviral vectors expressing CFTR.
| |
Materials and Methods |
|---|
|
|
|---|
NEC Culture
Primary cultures of NECs were established using a modification of a previously described technique (9). A 3-mm
bronchoscope cytology brush (BARD, Tewksbury, MA)
was used to obtain brush biopsies from under the inferior
nasal turbinate of pediatric patients undergoing flexible
bronchoscopy; clinical characteristics of the patients are
shown in Table 1. For children with CF, the diagnosis was
confirmed by typical clinical manifestations and sweat
chloride > 60 mEq/liter; four of the six children with CF were also known to have the
F508/
F508 genotype. Control children were undergoing bronchoscopy for evaluation of airway obstruction and did not have clinical features
of CF. The cells were transported in room temperature
RPMI 1640 medium (JRH Biosciences, Lenexa, KS) to the
laboratory, where brushes and cells were placed in 3 mM
dithiothreitol (DTT; Sigma Chemical Co., St. Louis, MO)
and phosphate-buffered saline (PBS) for 15 min. Cells were
then washed from the brush with PBS and centrifuged at
500 × g for 5 min. The cells were resuspended in serum-free
bronchial epithelial cell growth medium (BEGM; Clonetics, Walkersville, MD) with added antibiotics (100 µg/ml
ceftazidime, 80 µg/ml tobramycin, 100 µg/ml colistimethate
sodium, and 2.5 µg/ml amphotericin B). Cells were plated
on collagen-coated 25-cm2 culture flasks. (Coating was created by diluting human placental collagen type IV [Sigma]
to 0.05 mg/ml with sterile water and 0.02% acetic acid, adding 3 ml to flasks, drying for 18 h, and rinsing twice.) Attached cells were washed after 12 h and medium was changed
every 24 h. The added antibiotics were discontinued after
72 h. Cells were grown to confluence (average 10 d), lifted with 0.1% trypsin with 1 mM ethylenediamine tetraacetic
acid (EDTA) (Sigma), passaged onto collagen-coated multiwell culture plates, and again allowed to grow to 80-90%
confluence. Immunohistochemical staining of cells using
mouse monoclonal antibodies for human epithelial-specific
antigen (NCL-ESA; Novocastra Labs, Newcastle upon Tyne,
UK) or human cytokeratin 5, 6, 8, and 18 (NCL-PAN-CK; Novocastra Labs) was positive in all cells.
|
Stimulation of Primary NEC Cultures
Cell monolayers were incubated for 1 h with 300 µl of
BEGM containing 12.5 ng/ml TNF-
(Sigma) or 2 pfu/cell
RSV (ATCC, Rockville, MD; purified by sucrose-gradient
centrifugation as previously described [10]) or no additive
as a control. After 1 h, supernatants were aspirated, wells
were washed once with BEGM, and 1 ml BEGM was added
to each well. Supernatants for cytokine assays were collected and stored at
80°C, and fresh medium was added
at 4, 8, 24, and 48 h after the initial incubation period. After the 48-h collection, cells were detached with 0.1% trypsin
with 1 mM EDTA and counted. For wells inoculated with
RSV, productive infection was verified by formation of typical syncytia after placement of 48-h supernatant on HEp2
cells (ATCC) as previously described (11).
Stimulation of Primary NEC Cultures Corrected by Adenoviral Gene Transfer
In separate experiments, CF NEC cultures underwent restoration of CFTR function through a recombinant adenovirus vector driven by a cytomegalovirus (CMV) enhancer/
-actin promoter (Ad5-CBCFTR) as previously
described (12). Controls consisted of noninfected NEC
and Ad5-CMVLacZ (CMV enhancer/CMV promoter) infected NEC from the same donors. Adenoviral vectors
were obtained from the UNC Gene Therapy Core. In
these experiments, CF NEC were grown to confluence in
BEGM on six well plates. Cultures were incubated for 2 h
with either 200 µl BEGM (noninfected control), 200 µl BEGM with 103 pfu/cell of Ad5-CBCFTR, or 200 µl
BEGM with 103 pfu/cell of Ad5-CMVLacZ. Cells were
then washed with BEGM, incubated overnight, and stimulated with 12.5 ng/ml TNF-
for 1 h. Cells were again washed
with BEGM and 2 ml of BEGM were added. Supernatants were collected for cytokine assay and fresh medium was
added at 4, 8, and 24 h after the TNF-
stimulation.
Correction of CFTR function by gene transfer was estimated with a previously described chloride-efflux assay
(13). Briefly, after cytokine stimulation experiments were
completed, the rate of loss of chloride in noninfected,
Ad5-CBCFTR infected, was compared with that in Ad5-CMVLacZ infected cells. Wells were loaded with radioactive chloride (36Cl
) by incubating in 5 µCi 36Cl
for 1 h.
Cells were washed and aliquots of isotope-free, chloride-free Ringer's solution + 10
4 M amiloride were added and
collected at 1-min intervals. To assess cyclic adenosine
monophosphate (cAMP)-mediated chloride permeability, 10
5 M forskolin (final concentration) was added after the
second minute of the assay. After 10 min the cells were lysed with 0.1% sodium dodecyl sulfate (SDS) (Sigma). The
amounts of 36Cl
in the efflux aliquots and cell layer were
determined by liquid scintillation counting. Efflux curves
were plotted as the percent of counts remaining in the cells
versus time.
The proportion of NEC transfected with Ad5-CMVLacZ was estimated by X-gal staining at 48 h as previously
described (14). Briefly, cells were washed with PBS, fixed
in 0.5% glutaraldehyde for 10 min, then stained with X-gal
solution (Sigma) for 3 h, washed, and stored in 70% glycerol. Noninfected cells were used as controls. The development of any blue color in the cytoplasm indicated the
presence of
-galactosidase activity.
Immortalized Cell Lines
To establish further whether IL-8 release was related to
the presence of functioning CFTR, a third set of experiments, using three immortalized cell lines, was performed.
Human papilloma virus (HPV)-immortalized tracheal epithelial cells derived from a patient with CF homozygous
for
F508 (CFT1 cells) have been described (15). The
CFT1 cells retain a well-differentiated phenotype, including the bioelectric properties characteristic of CF (15). A
cell line corrected for the apical chloride channel defect
was derived from CFT1 cells by retroviral insertion of a
wild-type copy of CFTR cDNA (LCFSN cells) (16). A retrovirus encoding an irrelevant transgene, LacZ, was also
used to create a stable CFT1 cell line expressing LacZ
(LC3 cells) (17). All cell lines were grown on plastic in
Ham's F-12 base medium with seven hormones and growth
supplements as described (15), and were passaged every 7 to 10 d. Cells were seeded onto collagen-coated 24-well
plates, grown to confluence, and stimulated with TNF-
in
an identical fashion as that described for primary NEC
cultures.
IL-8 Assays
IL-8 in unconcentrated cell culture supernatants was measured with an enzyme-linked immunosorbent assay (ELISA) (Quantikine IL-8; R&D Systems, Minneapolis, MN). The lower detection limit of the IL-8 assay is 10 pg/ml, and the dynamic range is 31.2 to 2,000 pg/ml. The correlation coefficient of standard curves for all assays was > 0.98. Cross-reactivity or interference with the assay by other recombinant human cytokines is below the limits of detection according to the manufacturer.
Statistical Analysis
Comparisons of cytokine production by CF and non-CF NEC were made with an unpaired t test. Noninfected, Ad5-CBCFTR infected, and Ad5-CMVLacZ infected CF cell comparisons for identical cell donors were made with repeated measures analysis of variance (ANOVA) with Bonferroni's correction for multiple comparisons after testing. Data from immortalized cell lines were compared through ANOVA with Bonferroni's correction after testing. For all culture systems, the effect of a stimulus was assessed versus unstimulated controls by paired t test at each time point. P < 0.05 was defined as statistically significant. All data were log transformed for analysis. Analyses were done with a statistical software package (InStat2; Graphpad Software Inc., San Diego, CA).
| |
Results |
|---|
|
|
|---|
Primary NEC Stimulation
Release of IL-8 into primary culture supernatants was assessed. Production of IL-8 was normalized to cell count for
each condition and was expressed as pg/103 cells/h. When
compared with unstimulated controls, TNF-
induced a
significant increase in IL-8 release at 4 h after stimulation by both CF and control NEC (Figure 1). When IL-8 responses were compared in CF and non-CF control NEC,
there were no differences in either baseline or TNF-
stimulated IL-8 release at any time point.
|
RSV-infected wells had a significant increase in IL-8 release at 4 h after inoculation with virus (Figure 2). For both CF and non-CF control NEC, IL-8 levels in infected wells were not statistically different from baseline levels at 8 h after inoculation with virus (data not shown) or at 24 h after inoculation with virus, but were increased at 48 h after inoculation with virus. The amount of IL-8 released by CF NEC did not differ from that released by non-CF control NEC at any time point. Plaque formation in HEp2- cell monolayers inoculated with NEC supernatants confirmed that RSV-inoculated NEC were shedding virus at 48 h after inoculation with virus (data not shown).
|
CF NEC Correction with Adenoviral Gene Transfer
We assessed CFTR function with the chloride efflux assay. Transduction of CF cells with Ad5-CMVLacZ did not change the chloride efflux curve of these cells from that of nontransduced cells. CF cells transduced with Ad5-CBCFTR showed increased chloride efflux as compared with nontransduced and Ad5-CMVLacZ transduced CF cultures, indicating expression of functional CFTR (Figure 3). The transduction of virtually all of the Ad5-CMVLacZ cells, as indicated by X-gal staining, suggests a similar transduction efficiency in Ad5-CBCFTR transduced cells (Figure 4). Thus, transduction of CF NEC with adenoviral vectors at a multiplicity of infection (MOI) of 103 pfu/cell restored CFTR-mediated chloride transport in most of the cells.
|
|
All three cell types (nontransduced, Ad5-CBCFTR transduced, and Ad5-CMVLacZ transduced) had increased IL-8
production 4 h after TNF-
stimulation (Figure 5). However,
neither baseline nor stimulated IL-8 release differed significantly among the three lines.
|
Immortalized Cell Lines
All three immortalized cell lines showed a significant IL-8
response at 4 h after TNF-
stimulation (Figure 6). When
individual cell lines were compared, LCFSN (corrected
CF) cells had higher baseline IL-8 release than did CFT1
or LC3 cells (P < 0.01). Among the three cell lines at 4 h
after TNF-
stimulation, the LCFSN (corrected CF) cells
produced more IL-8 than did LC3 (sham corrected CF)
cells (P < 0.05), but this difference was not significant when the data were expressed as percent of unstimulated
control values. No other differences in IL-8 release after
TNF-
were noted among the cell lines.
|
| |
Discussion |
|---|
|
|
|---|
We have found that primary cultures of NEC from young
children release increased amounts of the neutrophil-attracting chemokine IL-8 soon after a short exposure to TNF-
,
and both early and late after inoculation with RSV. These
results are consistent with previously reported experiments
done with human respiratory epithelial cell cultures (6, 10,
18). Because levels of both IL-8 and neutrophils are unusually high in children with CF (3, 4), we hypothesized that
CF airway epithelial cells would overproduce IL-8 and that
this would be related to abnormal CFTR function. However, comparison of NEC cultures from children with CF
and similar cultures from children without CF showed no differences in the magnitude or duration of the IL-8 response to these stimuli.
Furthermore, restoration of CFTR function by transduction of CF cultures with Ad5-CBCFTR had no significant effect on the IL-8 response to TNF-
. These results
suggest that CFTR dysfunction alone does not induce excess IL-8 production under these culture conditions and in
response to this stimulus. To maintain consistency of cell
culture conditions throughout the study, we used a qualitative assay (chloride efflux) to assess whether cells were effectively transduced. Thus, a caveat is that we did not necessarily demonstrate full correction of CFTR function to
normal levels. However, the choice of adenoviral MOI
used in these experiments was based on our previously
published experience, which showed that electrophysiologic correction of CF epithelial cell layers requires that a
minority of cells be transduced, and that an MOI of 103 resulted in production of
-galactosidase in most cells as reflected both by X-gal staining and immunohistochemical
staining (14, 19), a result matched in the current study. It is
presumed that there is some variability in efficiency of adenovirus-mediated gene transfer even in cultured cells, and
that this accounts for the variability in staining intensity
shown in Figure 4, but it seems unlikely that an overall undercorrection of CFTR function could have accounted for
our negative results.
A further finding was that immortalized CF cells did
not show increased IL-8 responses compared with retrovirally corrected cells derived from the same line. This finding is consistent with that of Bédard and colleagues (20),
who also compared immortalized CF and non-CF NEC. Our
experiments with immortalized cell lines actually showed
trends toward lower IL-8 production in the cell lines with
CFTR dysfunction (CFT1 and LC3). TNF-
-stimulated IL-8 release expressed as a percent increase over that of unstimulated controls did not differ among the immortalized
cell lines, but there appeared to be lower basal IL-8 production in the CFT1 and LC3 lines.
In order to test the general IL-8 responsiveness of CF
epithelium, we stimulated our cultures with agents likely
to affect both CF and non-CF airways. TNF-
is a proinflammatory cytokine produced by macrophages and other
cell types as part of the early inflammatory cascade in a variety of conditions (21). RSV is the most common
lower respiratory pathogen in children and may be an
early trigger of chronic respiratory symptoms in children with CF (24). Our results contrast with those reported by
DiMango and associates who found significantly increased
production of IL-8 by immortalized CF airway epithelial
cells, as compared with the same cell line with corrected
CFTR expression, after adherence of Pseudomonas bacteria (25). It is possible that CFTR function has significant
effects on expression of factors with specific relevance to
CF, such as receptors for Pseudomonas, while having little
effect on more general IL-8 induction pathways, such as those stimulated in our experiments.
The use of NEC in primary culture to study respiratory epithelial functions in CF has several advantages. The bioelectric and histologic properties of epithelium on the inferior surface of the nasal turbinates in CF patients are very similar to those in the trachea and large bronchi (8, 26), suggesting similar expression of the CFTR abnormality in these portions of the airway. The cytology brush method for obtaining cells is relatively noninvasive and is not limited to patients undergoing surgical removal of airway tissue. It is therefore possible to choose cell donors based on genotype or clinical expression of disease. The use of primary cultures also avoids the potential problem of alteration in basal cytokine production by immortalization, which may have been illustrated by our data for LC3, LCFSN, and CFT1 cell lines. Furthermore, the nasal passages are not chronically inflamed early in childhood in CF (4), so that the epithelial cells obtained for culture have probably not had long-term exposure to factors that might alter their cytokine-producing characteristics. A potential limitation of this approach is that under our culture conditions the epithelium is relatively poorly differentiated. In particular, it is possible that the full effects of CFTR dysfunction on epithelial processes are not apparent unless full differentiation, including cell polarization or factors in the in vivo airway epithelial environment, are also present. Moreover, the extent to which respiratory epithelium from the upper or central lower airways functionally mimics that from small airways is unknown. The latter factor is of potential importance because current evidence indicates that obstruction of small airways is one of the earliest abnormalities in the CF lung (27).
In summary, we conclude from our data that CF NEC
in primary culture do not produce excessive amounts of
the neutrophil-attracting factor IL-8 in vitro, either at
baseline or after stimulation with the nonspecific IL-8 inducing agents TNF-
and RSV; and that CFTR dysfunction alone is not sufficient to cause significant nasal epithelial overproduction of IL-8 under the culture conditions used in our study. These findings do not support the hypothesis that epithelial IL-8 release is a primary pathologic
event in CF airways. Our findings may also be consistent
with those in a recent study by Armstrong and coworkers
(28), in which BAL was performed in 46 newly diagnosed
children with CF at a mean age of 2 mo. In the absence of
infection, these children had no increase in neutrophils,
neutrophil elastase, or IL-8 as compared with controls,
suggesting that at a very early age, little excess IL-8 or inflammation is present in children with CF without an infectious stimulus. However, epithelial IL-8 could still play an important role in the perpetuation of a cycle of inflammation and infection, as part of a "normal" reaction to
persistence of poorly cleared bacteria and activated neutrophils, or in response to a defect in resolution of inflammation, as has been suggested by studies involving the antiinflammatory cytokine IL-10 (29). Further investigation
of the role of airway epithelium in the relationship among
infection, inflammation, and airway secretions in CF is
needed.
| |
Footnotes |
|---|
Address correspondence to: Terry L. Noah, M.D., Pediatric Pulmonary Medicine, CB# 7220, 635 Burnett-Womack, UNC Hospitals, Chapel Hill, NC 27599-7220.
(Received in original form June 11, 1997 and in revised form December 3, 1997).
Acknowledgments: The authors wish to thank Ivo Wortman for expert technical assistance; John C. Olsen for the gift of LC3 and LCFSN cells; K. C. Blair, R.N., Pat Wilkins, R.T., and Robin Johnson, R.T., for assistance with biopsy procedures; Susan Boyles for assistance with the chloride efflux assay; Johnny Carson, Ph.D., and Luisa Brighton for assistance with cytokeratin staining; and Andrew McKenzie and Diana L. Walstad for assistance with cell culture. This study was supported by the Cystic Fibrosis Foundation (CFF grants BLACK96D0 and NOAH96P0) and the UNC Center for Enviromental Medicine and Lung Biology (U.S. EPA CR 817643).
Abbreviations
CF, cystic fibrosis;
CFTR, cystic fibrosis transmembrane regulator;
IL, interleukin;
NEC, nasal epithelial cell;
RSV, respiratory syncytial virus;
TNF-
, tumor necrosis factor-
.
| |
References |
|---|
|
|
|---|
1. Moss, R. B. 1993. Immunopathogenesis of cystic fibrosis lung disease. In Pediatric Respiratory Disease: Diagnosis and Treatment. B. C. Hilman, editor. W. B. Saunders Company, Philadelphia. 674-687.
2. Dean, T. P., Y. Dai, J. K. Shute, M. K. Church, and J. O. Warner. 1993. Interleukin-8 concentrations are elevated in bronchoalveolar lavage, sputum, and sera of children with cystic fibrosis. Pediatr. Res. 34: 159-161 [Medline].
3. Khan, T. Z., J. S. Wagener, T. Bost, J. Martinez, F. A. Accurso, and D. W. H. Riches. 1995. Early pulmonary inflammation in infants with cystic fibrosis. Am. J. Respir. Crit. Care Med. 151: 1075-1082 [Abstract].
4. Noah, T. L., H. R. Black, P. W. Cheng, R. E. Wood, and M. W. Leigh. 1997. Nasal and bronchoalveolar lavage fluid cytokines in early cystic fibrosis. J. Infect. Dis. 175: 638-647 [Medline].
5.
Richman-Eisenstat, J. B. Y.,
P. G. Jorens,
C. A. Hérbert,
I. Ueki, and
J. A. Nadel.
1993.
Interleukin-8: an important chemoattractant in sputum of patients with chronic inflammatory airway diseases.
Am. J. Physiol.
264:
L413-L418
6. Becker, S., H. S. Koren, and D. C. Henke. 1993. Interleukin-8 expression in normal nasal epithelium and its modulation by infection with respiratory syncytial virus and cytokines tumor necrosis factor, interleukin-1, and interleukin-6. Am. J. Respir. Cell Mol. Biol. 8: 20-27 .
7. Marini, M., E. Vittori, J. Hollemborg, and S. Mattoli. 1992. Expression of the potent inflammatory cytokines, granulocyte-macrophage-colony-stimulating factor and interleukin-6 and interleukin-8, in bronchial epithelial cells of patients with asthma. J. Allergy Clin. Immunol. 89: 1001-1009 [Medline].
8. Knowles, M. R., J. Gatzy, and R. C. Boucher. 1981. Increased bioelectric potential difference across respiratory epithelia in cystic fibrosis N. Engl. J. Med. 305: 1489-1495 [Abstract].
9. Bridges, M. A., D. C. Walker, and A. G. F. Davidson. 1991. Cystic fibrosis and control nasal epithelial cells harvested by a brushing procedure. In Vitro Cell. Dev. Biol. 27A:684-686.
10.
Noah, T. L., and
S. Becker.
1993.
Respiratory syncytial virus-induced cytokine production by a human bronchial epithelial cell line.
Am. J. Physiol
265:
L472-L478
11. Becker, S., J. Quay, and J. Soukup. 1991. Cytokine (tumor necrosis factor, IL-6, and IL-8) production by respiratory syncytial virus-infected human alveolar macrophages. J. Immunol. 147: 4307-4312 [Abstract].
12. Johnson, L. G., R. J. Pickles, S. E. Boyles, J. C. Morris, H. Ye, Z. Zhou, J. C. Olsen, and R. C. Boucher. 1996. In vitro assessment of variables affecting the efficiency and efficacy of adenovirus-mediated gene transfer to cystic fibrosis airway epithelia. Hum. Gene Ther 7: 51-59 [Medline].
13. Venglarik, C. J., R. J. Bridges, and R. A. Frizzell. 1990. A simple assay for agonist-regulated Cl and K conductances in salt-secreting epithelial cells. Am. J. Physiol 28: C358-C364 .
14. Noah, T. L., I. A. Wortman, P. C. Hu, M. W. Leigh, and R. C. Boucher. 1996. Cytokine production by cultured human bronchial epithelial cells infected with a replication-deficient adenoviral gene transfer vector or wild-type adenovirus type 5. Am. J. Respir. Cell Mol. Biol. 14: 417-424 [Abstract].
15.
Yankaskas, J. R.,
J. E. Haizlip,
M. Conrad,
D. Koval,
E. Lazarowski,
A. M. Paradiso,
C. A. Rinehart Jr.,
B. Sarkadi,
R. Schlegel, and
R. C. Boucher.
1993.
Papilloma virus immortalized tracheal epithelial cells retain a well-differentiated phenotype.
Am. J. Physiol.
264:
C1219-C1230
16. Olsen, J. C., L. G. Johnson, M. J. Stutts, B. Sarkadi, J. R. Yankaskas, R. Swanstrom, and R. C. Boucher. 1992. Correction of the apical membrane chloride permeability defect in polarized cystic fibrosis airway epithelia following retroviral-mediated gene transfer. Hum. Gene Ther. 3: 253-266 [Medline].
17. Olsen, J. C., and J. Sechelski. 1995. Use of sodium butyrate to enhance production of retroviral vectors expressing CFTR cDNA. Hum. Gene Ther 6: 1195-1202 [Medline].
18. Arnold, R., B. Humbert, H. Werchau, H. Gallati, and W. König. 1994. Interleukin-8, interleukin-6, and soluble tumor necrosis factor receptor type I release from a human pulmonary epithelial cell line (A549) exposed to respiratory syncytial virus. Immunology 82: 126-133 [Medline].
19. Grubb, B. R., R. J. Pickles, H. Ye, J. R. Yankaskas, R. N. Vick, J. F. Engelhardt, J. M. Wilson, L. G. Johnson, and R. C. Boucher. 1994. Inefficient gene transfer by adenovirus vector to cystic fibrosis airway epithelia of mice and humans. Nature 371: 802-806 [Medline].
20. Bédard, M., C. D. McClure, N. L. Schiller, C. Francoeur, A. Cantin, and M. Denis. 1993. Release of interleukin-8, interleukin-6, and colony-stimulating factors by upper airway epithelial cells: implications for cystic fibrosis. Am. J. Respir. Cell Mol. Biol. 9: 455-462 .
21. Warren, J. S.. 1990. Interleukins and tumor necrosis factor in inflammation. Crit. Rev. Clin. Lab. Sci. 28: 37-59 [Medline].
22. Rink, L., and H. Kirchner. 1996. Recent progress in the tumor necrosis factor-alpha field. Int. Arch. Allergy Immunol 111: 199-209 [Medline].
23.
Strieter, R. M.,
S. L. Kunkel, and
R. C. Bone.
1993.
Role of tumor necrosis
factor-
in disease states and inflammation.
Crit. Care Med
21:
S447-S463
[Medline].
24. Abman, S. H., J. W. Ogle, N. Butler-Simon, C. M. Rumack, and F. J. Accurso. 1988. Role of respiratory syncytial virus in early hospitalizations for respiratory distress of young infants with cystic fibrosis. J. Pediatr. 113: 826-830 [Medline].
25. DiMango, E., H. J. Zar, R. Bryan, and A. Prince. 1995. Diverse Pseudomonas aeruginosa gene products stimulate respiratory epithelial cells to produce interleukin-8. J. Clin. Invest. 96: 2204-2210 .
26. Knowles, M. R., J. L. Carson, A. M. Collier, J. T. Gatzy, and R. C. Boucher. 1981. Measurement of transepithelial electric potential differences in normal human subjects in vivo. Am. Rev. Respir. Dis. 124: 484-490 [Medline].
27. Mohon, R. T., J. S. Wagener, S. H. Abman, W. K. Seltzer, and F. J. Accurso. 1993. Relationship of genotype to early pulmonary function in infants with cystic fibrosis identified through neonatal screening. J. Pediatr 122: 550-555 [Medline].
28.
Armstrong, D. S.,
K. Grimwood,
J. B. Carlin,
R. Carzino,
J. P. Gutierrez,
J. Hull,
A. Olinsky,
E. M. Phelan,
C. F. Robertson, and
P. D. Phelan.
1997.
Lower airways inflammation in infants and young children with cystic fibrosis.
Am. J. Respir. Crit. Care Med.
156:
1197-1204
29. Bonfield, T. L., M. W. Konstan, P. Burfeind, J. R. Panuska, J. B. Hilliard, and M. Berger. 1995. Normal bronchial epithelial cells produce the anti- inflammatory cytokine interleukin-10, which is downregulated in cystic fibrosis. Am. J. Respir. Cell Mol. Biol. 13: 257-261 [Abstract].
This article has been cited by other articles:
![]() |
A. Elizur, C. L. Cannon, and T. W. Ferkol Airway Inflammation in Cystic Fibrosis Chest, February 1, 2008; 133(2): 489 - 495. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Dejima, S. H. Randell, M. J. Stutts, B. A. Senior, and R. C. Boucher Potential Role of Abnormal Ion Transport in the Pathogenesis of Chronic Sinusitis Arch Otolaryngol Head Neck Surg, December 1, 2006; 132(12): 1352 - 1362. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Zegarra-Moran, C. Folli, B. Manzari, R. Ravazzolo, L. Varesio, and L. J. V. Galietta Double Mechanism for Apical Tryptophan Depletion in Polarized Human Bronchial Epithelium J. Immunol., July 1, 2004; 173(1): 542 - 549. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. N. Becker, M. S. Sauer, M. S. Muhlebach, A. J. Hirsh, Q. Wu, M. W. Verghese, and S. H. Randell Cytokine Secretion by Cystic Fibrosis Airway Epithelial Cells Am. J. Respir. Crit. Care Med., March 1, 2004; 169(5): 645 - 653. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. L. Noah, P. C. Murphy, J. J. Alink, M. W. Leigh, W. M. Hull, M. T. Stahlman, and J. A. Whitsett Bronchoalveolar Lavage Fluid Surfactant Protein-A and Surfactant Protein-D Are Inversely Related to Inflammation in Early Cystic Fibrosis Am. J. Respir. Crit. Care Med., September 15, 2003; 168(6): 685 - 691. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Li, X. D. Johnson, S. Iazvovskaia, A. Tan, A. Lin, and M. B. Hershenson Signaling intermediates required for NF-kappa B activation and IL-8 expression in CF bronchial epithelial cells Am J Physiol Lung Cell Mol Physiol, February 1, 2003; 284(2): L307 - L315. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Saba, G. Soong, S. Greenberg, and A. Prince Bacterial Stimulation of Epithelial G-CSF and GM-CSF Expression Promotes PMN Survival in CF Airways Am. J. Respir. Cell Mol. Biol., November 1, 2002; 27(5): 561 - 567. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Sobol, P. Christodoulopoulos, J. J. Manoukian, H.-P. Hauber, S. Frenkiel, M. Desrosiers, M. Fukakusa, M. D. Schloss, and Q. Hamid Cytokine Profile of Chronic Sinusitis in Patients With Cystic Fibrosis Arch Otolaryngol Head Neck Surg, November 1, 2002; 128(11): 1295 - 1298. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Aldallal, E. E. McNaughton, L. J. Manzel, A. M. Richards, J. Zabner, T. W. Ferkol, and D. C. Look Inflammatory Response in Airway Epithelial Cells Isolated from Patients with Cystic Fibrosis Am. J. Respir. Crit. Care Med., November 1, 2002; 166(9): 1248 - 1256. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Y. Kazachkov, P.C. Hu, J. L. Carson, P. C. Murphy, F. W. Henderson, and T. L. Noah Release of Cytokines by Human Nasal Epithelial Cells and Peripheral Blood Mononuclear Cells Infected with Mycoplasma pneumoniae Experimental Biology and Medicine, May 1, 2002; 227(5): 330 - 335. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. O. Daines and G. K. K. Hershey A Novel Mechanism by Which Interferon-gamma Can Regulate Interleukin (IL)-13 Responses. EVIDENCE FOR INTRACELLULAR STORES OF IL-13 RECEPTOR alpha -2 AND THEIR RAPID MOBILIZATION BY INTERFERON-gamma J. Biol. Chem., March 15, 2002; 277(12): 10387 - 10393. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Kube, U. Sontich, D. Fletcher, and P. B. Davis Proinflammatory cytokine responses to P. aeruginosa infection in human airway epithelial cell lines Am J Physiol Lung Cell Mol Physiol, March 1, 2001; 280(3): L493 - L502. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Venkatakrishnan, A. A. Stecenko, G. King, T. R. Blackwell, K. L. Brigham, J. W. Christman, and T. S. Blackwell Exaggerated Activation of Nuclear Factor-kappa B and Altered Ikappa B-beta Processing in Cystic Fibrosis Bronchial Epithelial Cells Am. J. Respir. Cell Mol. Biol., September 1, 2000; 23(3): 396 - 403. [Abstract] [Full Text] |
||||
![]() |
L. Pizurki, M. A. Morris, M. Chanson, M. Solomon, A. Pavirani, I. Bouchardy, and S. Suter Cystic Fibrosis Transmembrane Conductance Regulator Does Not Affect Neutrophil Migration across Cystic Fibrosis Airway Epithelial Monolayers Am. J. Pathol., April 1, 2000; 156(4): 1407 - 1416. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. MUHLEBACH, P. W. STEWART, M. W. LEIGH, and T. L. NOAH Quantitation of Inflammatory Responses to Bacteria in Young Cystic Fibrosis and Control Patients Am. J. Respir. Crit. Care Med., July 1, 1999; 160(1): 186 - 191. [Abstract] [Full Text] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Proc. Am. Thorac. Soc. | Am. J. Respir. Crit. Care Med. |